Reviews on Recent Clinical Trials


Ludovico Abenavoli
University Magna Graecia


Become EABM
Become Reviewer

Treatment Options for Cystic Fibrosis: State of the Art and Future Perspectives

Volume:6   Issue: 2
Pp: 94-107
Edmund H. Sears, Eric J. Gartman and Brian P. Casserly
DOI: 10.2174/157488711795177859

The Role of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in Cardiovascular Disease

Volume:6   Issue: 2
Pp: 108-113
Ignatios Ikonomidis, Christos A. Michalakeas, John Lekakis, John Parissis and Maria Anastasiou-Nana
DOI: 10.2174/157488711795177903

Recent Clinical Evidence for the Treatment of Osteoarthritis: What we have Learned

Volume:6   Issue: 2
Pp: 114-126
Nidhi Sofat, Iain Beith, P. G. Anilkumar and Philip Mitchell
DOI: 10.2174/157488711795177886

Melanoma: The Radiotherapeutic Point of View; Review of the Current Literature

Volume:6   Issue: 2
Pp: 127-133
Zygogianni A., Kyrgias G., Kouvaris J., Mystakidou K., Gogas H. and Kouloulias V.
DOI: 10.2174/157488711795177877

Design and Endpoints of Clinical and Translational Trials in Advanced Colorectal Cancer. A Proposal from GROUP Español Multidisciplinar en Cancer Digestivo (GEMCAD)

Volume:6   Issue: 2
Pp: 158-170
Gemma Carrera, Xabier Garcia-Albeniz, Juan Ramon Ayuso, Jorge Aparicio, Antoni Castells, Jordi Codony-Servat, Jaime Feliu, David Fuster, Rosa Gallego, Mario Pages, Ferran Torres and Joan Maurel
DOI: 10.2174/157488711795177868

Tolvaptan: A New Therapeutic Agent

Volume:6   Issue: 2
Pp: 177-188
Georgios Aperis and Polichronis Alivanis
DOI: 10.2174/157488711795177895